Relationships between HbA1c and continuous glucose monitoring metrics of glycaemic control and glucose variability in a large cohort of children and adolescents with type 1 diabetes

被引:18
|
作者
Piona, Claudia [1 ]
Marigliano, Marco [1 ]
Mozzillo, Enza [2 ]
Rosanio, Francesco [2 ]
Zanfardino, Angela [3 ]
Iafusco, Dario [3 ]
Maltoni, Giulio [4 ]
Zucchini, Stefano [4 ]
Piccinno, Elvira [5 ]
Delvecchio, Maurizio [5 ]
Maffeis, Claudio [1 ]
机构
[1] Univ City Hosp Verona, Reg Ctr Pediat Diabet, Pediat Diabet & Metab Disorders Unit, Ple Stefani, I-37126 Verona, Italy
[2] Univ Naples Federico II, Reg Ctr Pediat Diabet, Dept Traslat & Med Sci, Sect Pediat, Naples, Italy
[3] Univ Campania Luigi Vanvitelli, Reg Ctr Pediat Diabetol G Stoppoloni, Naples, Italy
[4] Univ Hosp Bologna St Orsola Malpighi, Paediat Endocrine Unit, Bologna, Italy
[5] Giovanni XXIII Children Hosp, Metab Disorder & Diabet Unit, Bari, Italy
关键词
Type; 1; diabetes; Children and adolescents; HbA1c; Continuous glucose monitoring; Metrics of glycaemic control; Glucose variability; SEVERE HYPOGLYCEMIA; HBA(1C); ADULTS; A1C; AVERAGE; RISK;
D O I
10.1016/j.diabres.2021.108933
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: To evaluate the relationships between HbA1c and Continuous Glucose Monitoring (CGM) metrics in children/adolescents with Type 1 Diabetes (T1D). Methods: HbA1c and real-life CGM data of the 12 weeks preceding its measurement were retrospectively collected from 654 children/adolescents with T1D. The relationships between HbA1c and CGM metrics were assessed by Spearman correlation coefficient. Par-ticipants were categorized into groups based on HbA1c and CGM metrics values. ANOVA was run across HbA1c and CGM metrics groups in the entire study population and in sub-jects stratified by CGM type, insulin therapy, age and puberty. Results: HbA1c was positively correlated with mean glucose, SD, %TAR > 180 mg/dL, % TAR > 250 mg/dL, HBGI and negatively with %TIR, %TBR and %time < 54 mg/dL. HbA1c-based groups were significantly associated with these metrics, but for each group their value widely ranged with a substantial overlap between them. HbA1c and HbA1c-based groups were not associated with %CV and LBGI, as well as %CV and LBGI-based groups had not significantly different HbA1c. Comparable results were found analysing subjects according to age, type of CGM, insulin therapy and puberty. Conclusions: The relationships between HbA1c and CGM metrics described in this cohort of paediatric subjects with T1D support the importance of the evaluation of these metrics, in particular %CV and LBGI, independently of HbA1c value. (c) 2021 Elsevier B.V. All rights reserved.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Discrepancies between methods of continuous glucose monitoring in key metrics of glucose control in children with type 1 diabetes
    Michalak, Arkadiusz
    Pagacz, Konrad
    Mlynarski, Wojciech
    Szadkowska, Agnieszka
    Fendler, Wojciech
    PEDIATRIC DIABETES, 2019, 20 (05) : 604 - 612
  • [2] The importance of HbA1c and glucose variability in patients with type 1 and type 2 diabetes: outcome of continuous glucose monitoring (CGM)
    Sartore, Giovanni
    Chilelli, Nino Cristiano
    Burlina, Silvia
    Di Stefano, Paola
    Piarulli, Francesco
    Fedele, Domenico
    Mosca, Andrea
    Lapolla, Annunziata
    ACTA DIABETOLOGICA, 2012, 49 : S153 - S160
  • [3] High Glycemic Variability Is Associated with Worse Continuous Glucose Monitoring Metrics in Children and Adolescents with Type 1 Diabetes
    Piona, Claudia
    Marigliano, Marco
    Mozzillo, Enza
    Di Candia, Francesca
    Zanfardino, Angela
    Iafusco, Dario
    Maltoni, Giulio
    Zucchini, Stefano
    Delvecchio, Maurizio
    Maffeis, Claudio
    HORMONE RESEARCH IN PAEDIATRICS, 2022, 94 (9-10): : 369 - 373
  • [4] The importance of HbA1c and glucose variability in patients with type 1 and type 2 diabetes: outcome of continuous glucose monitoring (CGM)
    Giovanni Sartore
    Nino Cristiano Chilelli
    Silvia Burlina
    Paola Di Stefano
    Francesco Piarulli
    Domenico Fedele
    Andrea Mosca
    Annunziata Lapolla
    Acta Diabetologica, 2012, 49 : 153 - 160
  • [5] Evaluation of HbA1c and glucose management indicator discordance in a population of children and adolescents with type 1 diabetes
    Piona, Claudia
    Marigliano, Marco
    Mozzillo, Enza
    Di Candia, Francesca
    Zanfardino, Angela
    Iafusco, Dario
    Maltoni, Giulio
    Zucchini, Stefano
    Piccinno, Elvira
    Maffeis, Claudio
    PEDIATRIC DIABETES, 2022, 23 (01) : 84 - 89
  • [6] Associations between HbA1c and continuous glucose monitoring-derived glycaemic variables
    Hirsch, I. B.
    Welsh, J. B.
    Calhoun, P.
    Puhr, S.
    Walker, T. C.
    Price, D. A.
    DIABETIC MEDICINE, 2019, 36 (12) : 1637 - 1642
  • [7] The interrelationship of HbA1c and real-time continuous glucose monitoring in children with type 1 diabetes
    Ferenci, Tamas
    Koerner, Anna
    Kovacs, Levente
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2015, 108 (01) : 38 - 44
  • [8] Continuous Glucose Monitoring Time-in-Range and HbA1c Targets in Pregnant Women with Type 1 Diabetes
    Tundidor, Diana
    Meek, Claire L.
    Yamamoto, Jennifer
    Martinez-Bru, Cecilia
    Gich, Ignasi
    Feig, Denice S.
    Murphy, Helen R.
    Corcoy, Rosa
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 (10) : 710 - 714
  • [9] Associations between continuous glucose monitoring-derived metrics and HbA1c in patients with type 2 diabetes mellitus
    Kurozumi, Akira
    Okada, Yosuke
    Mita, Tomoya
    Wakasugi, Satomi
    Katakami, Naoto
    Yoshii, Hidenori
    Kanda, Kazuko
    Nishida, Keiko
    Mine, Shinichiro
    Tanaka, Yoshiya
    Gosho, Masahiko
    Shimomura, Iichiro
    Watada, Hirotaka
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 186
  • [10] The relationship between HbA1c values and the occurrence of hypoglycemia as assessed by continuous glucose monitoring in patients with type 1 diabetes
    Tsujino, Daisuke
    Nishimura, Rimei
    Onda, Yoshiko
    Seo, Chiaki
    Ando, Kiyotaka
    Morimoto, Aya
    Utsunomiya, Kazunori
    DIABETOLOGY & METABOLIC SYNDROME, 2016, 8